We are live on ! Find out more
AMAG

AMAG Pharmaceuticals
AMAG

Delisted

AMAG was delisted on the 13th of November, 2020.

187 hedge funds and large institutions have $774M invested in AMAG Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 68 increasing their positions, 54 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 20

26% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 54

7% more funds holding

Funds holding: 174187 (+13)

3% less capital invested

Capital invested by funds: $802M → $774M (-$28M)

76% less call options, than puts

Call options by funds: $3.87M | Put options by funds: $16.4M

Holders
187
Holders Change
+13
Holders Change %
+7.47%
% of All Funds
4.66%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
35
Increased
68
Reduced
54
Closed
20
Calls
$3.87M
Puts
$16.4M
Net Calls
-$12.5M
Net Calls Change
-$3.13M
Name Holding Trade Value Shares
Change
Change in
Stake
ZCM
126
Zebra Capital Management
Connecticut
$246K +$248K +13,332 New
CGH
127
Crossmark Global Holdings
Texas
$244K +$246K +13,226 New
MERSOM
128
Municipal Employees' Retirement System of Michigan
Michigan
$243K +$90.8K +4,870 +59%
PNC Financial Services Group
129
PNC Financial Services Group
Pennsylvania
$235K -$112K -6,008 -32%
CCMH
130
Cornerstone Capital Management Holdings
New York
$227K -$230K -12,350 -50%
KSCM
131
Kamunting Street Capital Management
Florida
$227K +$229K +12,300 New
GCA
132
Gideon Capital Advisors
New York
$216K +$219K +11,725 New
Jane Street
133
Jane Street
New York
$208K +$210K +11,273 New
USAA
134
United Services Automobile Association
Texas
$203K +$11.2K +600 +6%
AG
135
Aperio Group
California
$198K +$200K +10,730 New
CSS
136
Cubist Systematic Strategies
Connecticut
$197K +$199K +10,653 New
3C
137
361 Capital
Colorado
$197K +$199K +10,664 New
Group One Trading
138
Group One Trading
Illinois
$191K -$289K -15,519 -60%
HIMCH
139
Hartford Investment Management Co (HIMCO)
Connecticut
$186K +$187K +10,057 New
Baird Financial Group
140
Baird Financial Group
Wisconsin
$185K +$187K +10,021 New
TRSOTSOK
141
Teachers Retirement System of the State of Kentucky
Kentucky
$173K
Public Employees Retirement Association of Colorado
142
Public Employees Retirement Association of Colorado
Colorado
$169K
MSA
143
Mason Street Advisors
Wisconsin
$165K +$5.5K +295 +3%
Canada Pension Plan Investment Board
144
Canada Pension Plan Investment Board
Ontario, Canada
$144K -$242K -13,000 -63%
SOADOR
145
State of Alaska Department of Revenue
Alaska
$128K +$1.3K +70 +1%
AAM
146
Advisors Asset Management
Colorado
$120K -$4.96K -266 -4%
GHCM
147
Glen Harbor Capital Management
California
$117K +$32.3K +1,734 +38%
Barclays
148
Barclays
United Kingdom
$103K -$93.8K -5,031 -48%
MCIM
149
Meadow Creek Investment Management
Georgia
$96K +$26.6K +1,428 +38%
CL
150
CSS LLC
Illinois
$83K +$83.9K +4,500 New

AMAG Hedge Fund Activity: Q3 2017 in Review

187 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in AMAG Pharmaceuticals (AMAG) for Q3 2017, worth a combined $774M — down 3.5% from $802M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new AMAG positions and 20 closed out — a net gain of 15 holders — while 68 added to existing stakes and 54 trimmed.

The largest buyer was Camber Capital Management, adding an estimated $17.7M. The largest seller was Invesco, cutting an estimated $25.5M.

  • 187 institutional investors held AMAG Pharmaceuticals (AMAG) as of Q3 2017, up from 174 in Q2 2017.
  • Funds reported $774M of AMAG Pharmaceuticals stock for Q3 2017, down 3.5% quarter-over-quarter.
  • 35 funds opened new AMAG Pharmaceuticals positions in Q3 2017 and 20 closed out, a net change of +15 holders.
  • The largest AMAG Pharmaceuticals buyer in Q3 2017 was Camber Capital Management, an estimated $17.7M added.
  • The largest AMAG Pharmaceuticals seller in Q3 2017 was Invesco, an estimated $25.5M sold.

Based on aggregated 13F filings for Q3 2017.